Geneos Wealth Management Inc. cut its holdings in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 81.5% during the fourth quarter, HoldingsChannel reports. The fund owned 809 shares of the company’s stock after selling 3,572 shares during the period. Geneos Wealth Management Inc.’s holdings in Cardinal Health were worth $82,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in CAH. Panagora Asset Management Inc. lifted its holdings in Cardinal Health by 53.6% in the first quarter. Panagora Asset Management Inc. now owns 25,616 shares of the company’s stock valued at $1,452,000 after acquiring an additional 8,935 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in Cardinal Health by 4.8% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 37,071 shares of the company’s stock valued at $2,102,000 after acquiring an additional 1,702 shares during the last quarter. Cibc World Market Inc. acquired a new position in Cardinal Health in the first quarter valued at approximately $212,000. Blair William & Co. IL lifted its holdings in Cardinal Health by 6.7% in the first quarter. Blair William & Co. IL now owns 11,769 shares of the company’s stock valued at $667,000 after acquiring an additional 734 shares during the last quarter. Finally, Sei Investments Co. lifted its stake in Cardinal Health by 6.4% during the first quarter. Sei Investments Co. now owns 472,799 shares of the company’s stock worth $26,792,000 after purchasing an additional 28,568 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.
Cardinal Health Trading Up 1.8 %
NYSE:CAH opened at $107.03 on Tuesday. The firm has a market cap of $26.03 billion, a PE ratio of 42.14, a price-to-earnings-growth ratio of 1.01 and a beta of 0.68. The stock has a fifty day moving average price of $109.39 and a 200 day moving average price of $103.85. Cardinal Health, Inc. has a 12-month low of $77.56 and a 12-month high of $116.04.
Cardinal Health Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a $0.5006 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.87%. The ex-dividend date of this dividend was Thursday, March 28th. Cardinal Health’s dividend payout ratio is presently 78.74%.
Wall Street Analyst Weigh In
A number of research analysts have commented on the company. SVB Leerink assumed coverage on Cardinal Health in a research note on Monday, February 26th. They set an “outperform” rating and a $125.00 price target on the stock. TheStreet cut Cardinal Health from a “b-” rating to a “c+” rating in a research note on Wednesday, December 27th. UBS Group upped their price target on Cardinal Health from $122.00 to $125.00 and gave the stock a “buy” rating in a research note on Monday, February 5th. Argus upgraded Cardinal Health from a “hold” rating to a “buy” rating in a research note on Friday, February 9th. Finally, Leerink Partnrs restated an “outperform” rating on shares of Cardinal Health in a research note on Monday, February 26th. One research analyst has rated the stock with a sell rating, three have given a hold rating, seven have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $103.07.
Get Our Latest Research Report on Cardinal Health
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More
- Five stocks we like better than Cardinal Health
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- The Charles Schwab Company Can Hit New Highs
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- Quiet Period Expirations Explained
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.